文献速递慢性静脉疾病静脉血栓栓塞

腘静脉瘤管理的二十五年经验

Twenty-Five Years of Popliteal Venous Aneurysm Management.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-06-04

这项单中心回顾性队列研究分析了1998至2022年间54例腘静脉瘤患者的临床特征、治疗策略与结局。44%接受手术修复,56%保守治疗;3年一期和辅助通畅率分别为95±3%和100%,5年生存率94±4%,无PVA相关死亡。结果支持基于尺寸、症状和血栓存在的选择性手术干预,同时验证低危患者保守管理的可行性。

要点

  • 63%患者有症状,其中PE占15%、DVT占17%、疼痛占44%、可触及肿块占13%。
  • 手术修复以瘤壁切除加侧壁静脉修补为主(79%),其次为大隐静脉间置移植(21%)。
  • 3年一期通畅率95±3%,辅助通畅率100%,免于再干预率97±2%。

核心结论

  • 结果支持基于尺寸、症状和血栓存在的选择性手术干预,同时验证低危患者保守管理的可行性。
  • 5年生存率94±4%,无PVA相关死亡。

研究设计与样本

  • 回顾性单中心队列研究,纳入1998至2022年连续54例腘静脉瘤患者,平均年龄52.5±18岁(范围15-90)。
  • 分析人口学、术中细节和结局,主要终点为30天死亡率、长期移植物通畅率和再干预率。

主要发现

  • 54例中34例(63%)有症状,包括PE 8例(15%)、DVT 9例(17%)、疼痛24例(44%)、可触及肿块7例(13%)。
  • 31例(57%)为囊状动脉瘤;24例(44%)接受手术修复,其中19例(79%)有症状、5例(21%)无症状。
  • 30例(56%)保守治疗,包括15例有症状和15例无症状;中位随访31个月(范围1-134)。
  • 手术组早期并发症4例(16%),包括伤口裂开(4%)、移植物血栓形成(4%)和血肿(8%)。
  • 3年一期和辅助通畅率分别为95±3%和100%,免于再干预率97±2%。

关键数值与推荐

  • 最常见手术方式为瘤壁切除加侧壁静脉修补(19/24,79%),其次为大隐静脉间置移植(5/24,21%)。
  • 保守治疗的有症状患者中,13例症状缓解、1例无变化、1例新发DVT。
  • 保守治疗的无症状患者15例中,1例(3%)出现疼痛和肿胀,仍保守处理。
  • 随访期间2例复发有症状PVA,仅1例需手术。

临床怎么用

  • 对有症状、尺寸较大或存在血栓的PVA患者可考虑手术干预。
  • 低危患者(无症状、尺寸小、无血栓)可安全选择保守管理并密切随访。

局限性

  • 回顾性单中心设计,样本量较小(54例),可能存在选择偏倚。
  • 中位随访31个月,部分患者随访时间较短(范围1-134个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Popliteal venous aneurysms (PVAs) are a rare vascular disease that can lead to deep vein thrombosis (DVT) and pulmonary embolism (PE). There are limited data on optimal management. This retrospective, single centre cohort study, conducted over a 25 year period (1998 - 2022), evaluated the clinical features, treatment strategies, and outcomes in patients with PVAs. METHODS: Demographics, intra-operative details, and outcomes of all consecutive patients with PVA treated surgically or conservatively were analysed. Primary endpoints were 30 day mortality rate, long term graft patency, and re-intervention rates. RESULTS: Fifty-four patients (mean age 52.5 ± 18 years; range 15 - 90) were included. Thirty-four of the 54 (63%) patients had symptoms, including PE in eight (15%), DVT in nine (17%), pain in 24 (44%), and palpable mass in seven (13%). Thirty-one (57%) of the PVAs were saccular. Twenty-four (44%) patients underwent surgical repair, 19 of 24 (79%) were symptomatic and five of 24 (21%) were asymptomatic. The remaining 30 patients (56%) were managed conservatively, including 15 symptomatic and 15 asymptomatic. Tangential aneurysmectomy with lateral venorrhaphy was the most common procedure (19 of 24, 79%), followed by saphenous vein interposition graft in five of 24 (21%). Four (16%) patients experienced early complications, including wound dehiscence (4%), graft thrombosis (4%), and haematoma (8%). During a median follow up of 31 months (range 1 - 134), two patients had recurrent symptomatic PVA, only one requiring surgery. Among symptomatic patients managed conservatively, symptoms resolved in 13, were unchanged in one, and one developed new DVT. Among asymptomatic patients initially treated conservatively (15 of 30), one (3%) developed pain and swelling, which was managed conservatively. The 3 year primary and assisted patency rates were 95 ± 3% and 100%, respectively. Freedom from re-intervention was 97 ± 2%. Five year survival was 94 ± 4%, with no PVA related deaths. CONCLUSIONS: The results support selective operative intervention based on size, symptoms, and thrombus presence, while validating conservative management in low risk patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Al Ibraheem B, Sen I, Almhanni G, et al. Twenty-Five Years of Popliteal Venous Aneurysm Management. Eur J Vasc Endovasc Surg. 2026. PMID: 42248321. doi:10.1016/j.ejvs.2026.05.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。